The alteration of MiR-222 and its target genes in nickel-induced tumor

Biological Trace Element Research

Volumn 152, Issue 2, 2013, Pages 267-274

  Zhang, Jing ^a,b   Zhou, Yang ^a   Ma, Lin ^a   Huang, Shunquan ^b   Wang, Ruijin ^a   Gao, Rongrong ^b   Wu, Youjun ^b   Shi, Hongjun ^a   Zhang, Jun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

16HBE; CDKN1B; CDKN1C; miR 222; Nickel

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; MICRORNA 222; NICKEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CDKN1B GENE; CDKN1C GENE; CELL PROLIFERATION; CONTROLLED STUDY; DNA LIBRARY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; RAT; UPREGULATION;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; NEOPLASMS; NICKEL; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION;

RATTUS;

EID: 84877876751     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-013-9619-6     Document Type: Article

References (34)

1. Li Q, Suen TC, Sun H, Arita A, Costa M (2009) Nickel compounds induce apoptosis in human bronchial epithelial Beas-2B cells by activation of c-Myc through ERK pathway. Toxicol Appl Pharmacol 235:191-198
2. Doll R, Morgan LG, Speizer FE (1970) Cancers of the lung and nasal sinuses in nickel workers. Br J Cancer 24:623-632
3. Sutherland JE, Peng W, Zhang QW, Costa M (2001) The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. Mutat Res Fundam Mol Mech Mutagen 479:225-233
4. Costa M, Davidson TL, Chen HB, Ke QD, Zhang P, Yan Y et al (2005) Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res Fundam Mol Mech Mutagen 592:79-88
5. Bartel DP (2007) MicroRNAs: genomics, biogenesis, mechanism, and function (reprinted from Cell, vol 116, pg 281-297, 2004). Cell 131:11-29
6. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259-269
7. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S et al (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27:5651-5661
8. Ohmori T, Okada K, Terada M, Tabei R (1999) Low susceptibility of specific inbred colonies of rats to nickel tumorigenesis in soft tissue. Cancer Lett 136:53-58
9. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408
10. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798
11. Wang WC, Shi CY, Zhang JS, Gu WT, Li TJ, Gen MM, Chu WY, Huang RL, Liu YL, Hou YQ, Li P, Yin YL (2009) Molecular cloning, distribution and ontogenetic expression of the oligopeptide transporter PepT1 mRNA in Tibetan suckling piglets. Amino Acids 37:593-601
12. Lee Y-W, Broday L, Costa M (1998) Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels. Mutat Res 3:213-218
13. Golebiowski F, Kasprzak KS (2005) Inhibition of core histones acetylation by carcinogenic nickel(II). Mol Cell Biochem 279:133-139
14. Yan Y, Kluz T, Zhang P, Chen H-b, Costa M (2003) Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Toxicol Appl Pharmacol 3:272-277
15. Huang X, Zhuang Z, KF R, (1994) The role of nickel and nickel-mediated reactive oxygen species in the mechanism of nickel carcinogenesis. Environ Health Perspect 120:281-284
16. 2+ compounds. Cancer Res 58(10):2182-2189
17. Calin GA et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 105:7004-7009
18. Zhang B, Pan X, Cobb GP, Anderson TA (2007) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12
19. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65:9628-9632
20. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC (2005) MiR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204:280-285
21. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524-15529
22. Tang J-T, Wang J-L, Wan D, Hong J, Zhao S-L, Wang Y-C, Xiong H, Chen H-M, Fang J-Y (2011) MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis 8:1207-1215
23. Weber B, Stresemann C, Brueckner B, Lyko F (2007) Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6:1001-1005
24. Shen HM, Zhang QF (1994) Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 102(Suppl 1):275-282
25. Grimsrud TK, Berge SR, Haldorsen T, Andersen A (2002) Exposure to different forms of nickel and risk of lung cancer. Am J Epidemiol 156(12):1123-1132
26. Gao W, Shen H, Liu L, Jian X, Jing X, Shu Y (2011) MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. Cancer Res Clin Oncol 4:557-566
27. Gang Y, Guodong F, Cui S, Zhao S, Bernaudo S, Bai Y, Ding Y, Zhang Y, Yang BB, Peng C (2011) MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase7: implications for chemoresistance. Cell Science 124:359-368
28. Hwang J-H, Voortman J, Giovannetti E, Steinberg SM, Leon LG et al (2010) Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One 5(5):e10630
29. Carlos le S, Nagel R, Egan DA, Schrie M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA, Farace MG, Agami R (2007) Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708
30. Sun K, Wang W, Zeng J-j, Cheng-tang W, Lei S-t, Li G-x (2011) MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacologica Sinica 32:375-384
31. Lee MH, Reynisdottir I, Massague J (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649
32. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A et al (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662
33. Susaki E, Nakayama KI (2009) Functional similarities and uniqueness of p27 and p57: insight from a knock-in mouse model. Cell Cycle 8:2497-2501
34. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708